NOTICE – The Fonds de recherche du Québec (FRQ) was established on June 1, 2024, in accordance with the Act to amend the Act respecting the Ministère de l’Économie et de l’Innovation with respect to research. The Fonds de recherche du Québec – Nature et technologies (FRQNT), the Fonds de recherche du Québec – Santé (FRQS) and the Fonds de recherche du Québec – Société et culture (FRQSC) have since been regrouped into the new FRQ, which continues their existence. The rights and obligations of the FRQNT, FRQS and FRQSC have become those of the FRQ; activities continue as usual.

Please note that if you come across an old name or logo of one of the Fonds de recherche du Québec in the program rules or on the website, it should now read as follows:

  • The FRQNT becomes the Nature et technologies sector;
  • The FRQS becomes the Santé sector;
  • The FRQSC becomes the Société et culture sector.

Thank you for your understanding.

Competition year : 
2018-2019

Deadline (pre-request) : 
January 16th, 2018 at 11:00 (EST)

Deadline (application) : 
May 30th, 2018 at 11:00 (EST)

Announcement of results : 
September 2018

Amount : 
Maximum of $ 225 000 CAD per Quebec team

Duration : 
3 years

Back to programs

The Euronanomed 3 network, in which the Fonds de recherche du Québec – Santé (FRQS) is a partner, is launching a multilateral joint transnational call for proposals to support research in the field of nanomedicine.

The aims of the call are:

  • To support translational research projects that combine innovative approaches in the  field of nanomedicine and;
  • To encourage and enable transnational collaboration between public and private  research groups from academia (research teams from universities, higher education institutions, public research institutions) and clinical/public health research (research teams from hospital/ public health, healthcare settings and other healthcare organisations) or research teams from industrial enterprises (all size).

Project proposals will address multidisciplinary and translational research. The project proposals must cover at least one of the following areas that are equal in relevance for this call:
a.    Regenerative medicine
b.    Diagnostics
c.    Targeted delivery systems
The projects should fall within Technology Readiness Levels (TRL) 3-6, although for being realistic and coherent with the characteristics of the call, projects should propose advancements for a maximum of two TRL levels during their lifetime.
For more information: EuroNanoMed website